Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Study of TAS0612 in Patients With Locally Advanced or Metastatic Solid Tumors

NCT04586270 is registered in ClinicalTrials.gov with Taiho Oncology, Inc. as lead sponsor.

NCT NCT04586270
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04586270 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Study of TAS0612 in Patients With Locally Advanced or Metastatic Solid Tumors
Lead sponsor
Taiho Oncology, Inc.
Phase
Phase 1
Overall status
Terminated
Start date
October 15, 2020
Completion date
November 14, 2024
Enrollment
47 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

advanced or metastatic solid tumors